Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yeon Woo Kang"'
Autor:
Dong-il Kwon, Eun Seo Park, Mingyu Kim, Yoon Ha Choi, Myeong-seok Lee, Si-hyung Joo, Yeon-Woo Kang, Minji Lee, Saet-byeol Jo, Seung-Woo Lee, Jong Kyoung Kim, You Jeong Lee
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
Elevated levels of IgE is associated with a range of allergic pathology but the source of such IgE producing B cells during the steady state is poorly understood. Here, Kwon et al. show that homeostatic IgE is secreted by plasma cells in the thymus a
Externí odkaz:
https://doaj.org/article/9fc5e2f220d84245abdc89ac1607c7e7
Autor:
Ji‐Hae Kim, Young‐Min Kim, Donghoon Choi, Saet‐byeol Jo, Han Wook Park, Sung‐Wook Hong, Sujeong Park, Sora Kim, Sookjin Moon, Gihoon You, Yeon‐Woo Kang, Yunji Park, Byung Ha Lee, Seung‐Woo Lee
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Abstract Objectives Emerging oncotherapeutic strategies require the induction of an immunostimulatory tumor microenvironment (TME) containing numerous tumor‐reactive CD8+ T cells. Interleukin‐7 (IL‐7), a T‐cell homeostatic cytokine, induces a
Externí odkaz:
https://doaj.org/article/6242ddc420e346bca9fbc8618bfa5ff1
Autor:
Kun-Joo Lee student, Nara Tae, Yeon-Woo Kang, Dain Moon, Youngsik Oh, Ji-Hae Kim, Minji Lee, Ha Won Song, Sun Shim Choi, Donghoon Choi, Dae Hee Kim, Seung-Woo Lee
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Yang Sang-In, Sora Kim, Subin Park, Yeon-Woo Kang, Young-Min Kim, Donghoon Choi, Seung-Woo Lee, Young Chul Sung, Hyekang Kim
Publikováno v:
Leukemia
Autor:
Seung-Woo Lee, Shinai Lee, Wonjun Son, Eunyoung Park, Yunji Park, Park Kyeongsu, Sora Kim, Ji-Hae Kim, Yeon-Woo Kang, Yangsoon Lee, Jonghwa Won, Han Wook Park, Yong-Gyu Son, Jung Uijung, Young-Min Kim, Dain Moon, Gihoon You, Hyekang Kim, Eom Jaehyun, Chung Hyejin, Jaeho Jung
Publikováno v:
Science Advances. 7
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. Here, we developed a bispecific antibody (bsAb; B7-H3×4-1BB), targeting human B7-H3 (hB7-H3) and mouse or human 4-1BB, to restrict t
Publikováno v:
Immune Network
The emergence of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has become a significant health concern worldwide. Undoubtedly, a better understanding of the innate and adaptive immune responses against SARS-CoV-2 and its
Autor:
Yunji Park, Byung Ha Lee, Ji-Hae Kim, Seung-Woo Lee, Se Hwan Yang, Yeon-Woo Kang, Dae Hee Kim, Kun-Joo Lee, Donghoon Choi, S.S. Park, Dain Moon, Nara Tae
Publikováno v:
Regular and young investigator award abstracts.
Background rhIL-7-hyFc is a hybrid Fc-fused recombinant human interleukin-7 (NT-I7; efineptakin-alfa) with enhanced bioactivity. In a previous study, we found that a systemic administration of rhIL-7-hyFc induced antitumor effect by increasing CD8+ T
Autor:
Gihoon, You, Yangsoon, Lee, Yeon-Woo, Kang, Han Wook, Park, Kyeongsu, Park, Hyekang, Kim, Young-Min, Kim, Sora, Kim, Ji-Hae, Kim, Dain, Moon, Hyejin, Chung, Wonjun, Son, Ui-Jung, Jung, Eunyoung, Park, Shinai, Lee, Yong-Gyu, Son, Jaehyun, Eom, Jonghwa, Won, Yunji, Park, Jaeho, Jung, Seung-Woo, Lee
Publikováno v:
Science Advances
Tumor-targeted T cell costimulatory antibody augments antitumor immunity by enhancing tumor-killing T cells within the tumor.
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. He
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. He
Autor:
Ki-Sun Park, Yeon Woo Kang, Joong Hyeon Nam, Eun-Mi Kim, Jaewhan Kim, Namjoon Cho, Kee K. Kim, Myoung Soo Nam
Publikováno v:
Applied Biological Chemistry. 63
Dysfunction of tight junctions and their components can cause diverse skin diseases. Here, we investigated the expression of claudin 1, a major tight junction protein, and changes of tight junction capacity upon treatment of the extracts of Cudrania
Autor:
Sookjin Moon, Byung Ha Lee, Seung-Woo Lee, Young-Min Kim, Sora Kim, Yeon-Woo Kang, S.S. Park, Gihoon You, Ji-Hae Kim, Donghoon Choi, Saet-Byeol Jo, Yunji Park, Han Wook Park, Sung-Wook Hong
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Clinical & Translational Immunology
Clinical & Translational Immunology
Objectives Emerging oncotherapeutic strategies require the induction of an immunostimulatory tumor microenvironment (TME) containing numerous tumor‐reactive CD8+ T cells. Interleukin‐7 (IL‐7), a T‐cell homeostatic cytokine, induces an antitum